GlassScriptPhysician profile
Allison Buchanan Enter
NPI 1437372257
$3,086.99
in general payments reported to CMS, 2019-2025
28 companies · $614 in 2025
The $614 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $129 · 2020: $53.35 · 2021: $102 · 2022: $1,700 · 2023: $357 · 2024: $132 · 2025: $614.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,102.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,014.76 | 2021-2025 | Da Vinci Surgical System |
| Organogenesis INC. | $166.04 | 2021-2023 | Puraply |
| Hologic Sales and Service, LLC | $164.54 | 2022-2023 | Localizer, Trunode |
| Merck Sharp & Dohme LLC | $108.51 | 2023-2025 | Keytruda, Lynparza |
| Merit Medical Systems INC | $56.46 | 2023-2024 | Savi Scout |
| Molli Surgical (US) INC | $51.52 | 2022 | |
| Elucent Medical | $49.05 | 2022 | |
| Myriad Genetic Laboratories, INC. | $45.59 | 2024-2025 | Myrisk |
| Becton, Dickinson and Company | $44.14 | 2023 | |
| Tela Bio, INC. | $38.05 | 2019 | |
| Covidien LP | $30.16 | 2019 | |
| Davol INC. | $28.89 | 2025 | Phasix Mesh |
| Regeneron Healthcare Solutions, INC. | $26.57 | 2023 | Libtayo |
| Solventum Corporation | $25.49 | 2025 | Activ.A.C. |
| Acelrx Pharmaceuticals, INC. | $25.18 | 2019-2020 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $24.71 | 2025 | Irrisept |
| Boston Scientific Corporation | $20.88 | 2025 | Ams 700 |
| Portola Pharmaceuticals, LLC | $19.27 | 2019 | |
| Ethicon US, LLC | $17.27 | 2021 | |
| Access Pro Medical, LLC | $17.08 | 2023 | Matriderm |
| Focal Therapeutics, INC. | $15.42 | 2020 | |
| Genentech USA, INC. | $15.06 | 2019 | |
| Abbvie INC. | $14.92 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $14.72 | 2022 | |
| Mallinckrodt Hospital Products INC. | $14.27 | 2020 | |
| Shire North American Group INC | $13.40 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $13.10 | 2023 | Seglentis |
| Hologic INC | $11.94 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Enter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.